Recent Trends in the Treatment of Chronic Hepatitis C

被引：0
作者：
Erickson, Sara C. [1 ]
Qiu, Wenyi [1 ]
Maas-Patel, Crystal R. [1 ]
Wang, Sharon M. [1 ]
Patel, Bimal V. [1 ]
机构：
[1] Hlth Outcomes Res, San Diego, CA USA
来源：
AMERICAN JOURNAL OF PHARMACY BENEFITS | 2014年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：92 / 98
页数：7
相关论文
共 38 条
  • [1] [Anonymous], 2013, OL PRESCR INF
  • [2] The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
    Backx, M.
    Lewszuk, A.
    White, J. R.
    Cole, J.
    Sreedharan, A.
    van Sanden, S.
    Diels, J.
    Lawson, A.
    Neal, K. R.
    Wiselka, M. J.
    Ito, T.
    Irving, W. L.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 (03) : 208 - 215
  • [3] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
    Bacon, Bruce R.
    Gordon, Stuart C.
    Lawitz, Eric
    Marcellin, Patrick
    Vierling, John M.
    Zeuzem, Stefan
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Boparai, Navdeep
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Esteban, Rafael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) : 1207 - 1217
  • [4] Prospective multicenter study of eligibility for antiviral therapy among 4,084 US veterans with chronic hepatitis C virus infection
    Bini, EJ
    Bräu, N
    Currie, S
    Shen, H
    Anand, BS
    Hu, KQ
    Jeffers, L
    Ho, SB
    Johnson, D
    Schmidt, WN
    King, P
    Cheung, R
    Morgan, TR
    Awad, J
    Pedrosa, M
    Chang, KM
    Aytaman, A
    Simon, F
    Hagedorn, C
    Moseley, R
    Ahmad, J
    Mendenhall, C
    Waters, B
    Strader, D
    Sasaki, AW
    Rossi, S
    Wright, TL
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (08) : 1772 - 1779
  • [5] Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C:: A meta-analysis of individual patient data
    Cammà, C
    Di Bona, D
    Schepis, F
    Heathcote, EJ
    Zeuzem, S
    Pockros, PJ
    Marcellin, P
    Balart, L
    Alberti, A
    Craxì, A
    [J]. HEPATOLOGY, 2004, 39 (02) : 333 - 342
  • [6] Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies
    Chen, Jianmeng
    Florian, Jeffry
    Carter, Wendy
    Fleischer, Russell D.
    Hammerstrom, Thomas S.
    Jadhav, Pravin R.
    Zeng, Wen
    Murray, Jeffrey
    Birnkrant, Debra
    [J]. GASTROENTEROLOGY, 2013, 144 (07) : 1450 - U218
  • [7] PHARMACEUT ICALS Advocates Protest the Cost of a Hepatitis C Cure
    Cohen, Jon
    [J]. SCIENCE, 2013, 342 (6164) : 1302 - 1303
  • [8] Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
    Davis, Gary L.
    Alter, Miriam J.
    El-Serag, Hashem
    Poynard, Thierry
    Jennings, Linda W.
    [J]. GASTROENTEROLOGY, 2010, 138 (02) : 513 - U141
  • [9] Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
    Denniston, Maxine M.
    Jiles, Ruth B.
    Drobeniuc, Jan
    Klevens, R. Monina
    Ward, John W.
    McQuillan, Geraldine M.
    Holmberg, Scott D.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 160 (05) : 293 - +
  • [10] Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008
    Denniston, Maxine M.
    Klevens, R. Monina
    McQuillan, Geraldine M.
    Jiles, Ruth B.
    [J]. HEPATOLOGY, 2012, 55 (06) : 1652 - 1661
1234